Say It Ain't So Joe: Louisiana Supreme Court Reverses $300 Million+ Verdict Against Janssen

via Drug and Device Law;
Breaking News: Risperdal Megaverdict In Caldwell Reversed

This just in:  The Louisiana Supreme Court has reversed the $300 million+ state Medicare verdict in Caldwell v. Janssen Pharmaceutica, Inc., Nos. 2012-C-2447, -2466, slip op. (La. Jan. 28, 2014).  

. . . . . . .

Caldwell, slip op. 21-22.  More later after we’ve had time to digest this.